These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36939145)

  • 21. Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.
    Hidvégi E; Somogyi GP
    Pharmazie; 2010 Jun; 65(6):408-11. PubMed ID: 20614687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
    Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
    Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
    Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.
    Hinckley JD; Saba L; Raymond K; Bartels K; Klawitter J; Christians U; Hopfer C
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):65-77. PubMed ID: 33998853
    [No Abstract]   [Full Text] [Related]  

  • 25. Accuracy and replicability of identifying eyelid tremor as an indicator of recent cannabis smoking.
    Wang GS; Kosnett M; Subramanian P; Wrobel J; Ma M; Brown T; Bidwell LC; Brooks-Russell A
    Clin Toxicol (Phila); 2024 Jan; 62(1):10-18. PubMed ID: 38421358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use.
    Gibson LP; Gust CJ; Ellingson JM; YorkWilliams SL; Sempio C; Klawitter J; Bryan AD; Hutchison KE; Cinnamon Bidwell L
    Drug Alcohol Depend; 2021 Jun; 223():108718. PubMed ID: 33866072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users.
    Taylor M; Lees R; Henderson G; Lingford-Hughes A; Macleod J; Sullivan J; Hickman M
    Drug Alcohol Rev; 2017 Mar; 36(2):220-226. PubMed ID: 27296783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid concentrations in hair from documented cannabis users.
    Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
    Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Driving under the influence of cannabis: A 5-year retrospective Italian study.
    Favretto D; Visentin C; Aprile A; Terranova C; Cinquetti A
    Forensic Sci Int; 2023 Dec; 353():111854. PubMed ID: 37922577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.
    Newmeyer MN; Desrosiers NA; Lee D; Mendu DR; Barnes AJ; Gorelick DA; Huestis MA
    Drug Test Anal; 2014 Oct; 6(10):1002-10. PubMed ID: 24652685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles.
    Birenboim M; Chalupowicz D; Maurer D; Barel S; Chen Y; Fallik E; Paz-Kagan T; Rapaport T; Sadeh A; Kengisbuch D; Shimshoni JA
    Phytochemistry; 2022 Aug; 200():113215. PubMed ID: 35483556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.
    Lee D; Vandrey R; Mendu DR; Anizan S; Milman G; Murray JA; Barnes AJ; Huestis MA
    Clin Chem; 2013 Dec; 59(12):1770-9. PubMed ID: 23938457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.
    Lee D; Vandrey R; Milman G; Bergamaschi M; Mendu DR; Murray JA; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2013 Sep; 405(23):7269-79. PubMed ID: 23831756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
    Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
    J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socioeconomic, Ethnocultural, Substance- and Cannabinoid-Related Epidemiology of Down Syndrome USA 1986-2016: Combined Geotemporospatial and Causal Inference Investigation.
    Reece AS; Hulse GK
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids detected in exhaled breath condensate after cannabis use.
    Berry JL; Brooks-Russell A; Beuning CN; Limbacher SA; Lovestead TM; Jeerage KM
    J Breath Res; 2024 Jul; 18(4):. PubMed ID: 39008974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
    Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.